Wells Fargo’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.19K | Hold |
251
| – | – | ﹤0.01% | 6318 |
|
|
2025
Q4 | $4.54K | Hold |
251
| – | – | ﹤0.01% | 6119 |
|
|
2025
Q3 | $3.6K | Sell |
251
-700
| -74% | -$8.05K | ﹤0.01% | 6114 |
|
|
2025
Q2 | $7.34K | Hold |
951
| – | – | ﹤0.01% | 6020 |
|
|
2025
Q1 | $5.65K | Hold |
951
| – | – | ﹤0.01% | 6004 |
|
|
2024
Q4 | $12.7K | Sell |
951
-300
| -24% | -$3.16K | ﹤0.01% | 5884 |
|
|
2024
Q3 | $10.2K | Buy |
1,251
+936
| +297% | +$8.02K | ﹤0.01% | 5795 |
|
|
2024
Q2 | $2.68K | Sell |
315
-1,285
| -80% | -$19.3K | ﹤0.01% | 5976 |
|
|
2024
Q1 | $27.8K | Buy |
1,600
+185
| +13% | +$3.29K | ﹤0.01% | 5474 |
|
|
2023
Q4 | $18.1K | Sell |
1,415
-35
| -2% | -$816 | ﹤0.01% | 5670 |
|
|
2023
Q3 | $53.6K | Sell |
1,450
-531
| -27% | -$23.6K | ﹤0.01% | 5142 |
|
|
2023
Q2 | $79.7K | Sell |
1,981
-2,964
| -60% | -$168K | ﹤0.01% | 5172 |
|
|
2023
Q1 | $359K | Buy |
4,945
+4,435
| +870% | +$430K | ﹤0.01% | 4066 |
|
|
2022
Q4 | $41.8K | Sell |
510
-232
| -31% | -$24.2K | ﹤0.01% | 4950 |
|
|
2022
Q3 | $70K | Sell |
742
-518
| -41% | -$58.2K | ﹤0.01% | 4794 |
|
|
2022
Q2 | $246K | Buy |
1,260
+352
| +39% | +$57.5K | ﹤0.01% | 4167 |
|
|
2022
Q1 | $211K | Sell |
908
-1,219
| -57% | -$388K | ﹤0.01% | 4948 |
|
|
2021
Q4 | $837K | Sell |
2,127
-134
| -6% | -$56.4K | ﹤0.01% | 4262 |
|
|
2021
Q3 | $1.01M | Sell |
2,261
-4,017
| -64% | -$1.44M | ﹤0.01% | 4230 |
|
|
2021
Q2 | $2.44M | Sell |
6,278
-834
| -12% | -$297K | ﹤0.01% | 3508 |
|
|
2021
Q1 | $2.55M | Sell |
7,112
-818
| -10% | -$362K | ﹤0.01% | 3478 |
|
|
2020
Q4 | $3.89M | Buy |
7,930
+834
| +12% | +$385K | ﹤0.01% | 2972 |
|
|
2020
Q3 | $2.3M | Sell |
7,096
-30
| -0.4% | -$10.2K | ﹤0.01% | 3198 |
|
|
2020
Q2 | $2.6M | Buy |
7,126
+4,954
| +228% | +$1.25M | ﹤0.01% | 3067 |
|
|
2020
Q1 | $462K | Sell |
2,172
-1,936
| -47% | -$614K | ﹤0.01% | 4098 |
|
|
2019
Q4 | $1.69M | Sell |
4,108
-240
| -6% | -$82.7K | ﹤0.01% | 3480 |
|
|
2019
Q3 | $1.53M | Buy |
4,348
+267
| +7% | +$99.6K | ﹤0.01% | 3542 |
|
|
2019
Q2 | $2.05M | Buy |
4,081
+260
| +7% | +$184K | ﹤0.01% | 3340 |
|
|
2019
Q1 | $3.8M | Buy |
3,821
+109
| +3% | +$101K | ﹤0.01% | 2805 |
|
|
2018
Q4 | $3.22M | Buy |
3,712
+101
| +3% | +$93.8K | ﹤0.01% | 2860 |
|
|
2018
Q3 | $3.73M | Sell |
3,611
-11,856
| -77% | -$11.6M | ﹤0.01% | 2897 |
|
|
2018
Q2 | $14.2M | Buy |
15,467
+13,298
| +613% | +$14.3M | ﹤0.01% | 1771 |
|
|
2018
Q1 | $2.12M | Buy |
2,169
+345
| +19% | +$314K | ﹤0.01% | 3335 |
|
|
2017
Q4 | $825K | Sell |
1,824
-382
| -17% | -$141K | ﹤0.01% | 4050 |
|
|
2017
Q3 | $912K | Sell |
2,206
-69
| -3% | -$26K | ﹤0.01% | 3914 |
|
|
2017
Q2 | $796K | Sell |
2,275
-55
| -2% | -$21.2K | ﹤0.01% | 3898 |
|
|
2017
Q1 | $1.2M | Buy |
2,330
+192
| +9% | +$79.5K | ﹤0.01% | 3609 |
|
|
2016
Q4 | $759K | Buy |
2,138
+710
| +50% | +$301K | ﹤0.01% | 3911 |
|
|
2016
Q3 | $764K | Sell |
1,428
-46
| -3% | -$25K | ﹤0.01% | 3682 |
|
|
2016
Q2 | $830K | Buy |
1,474
+193
| +15% | +$92.6K | ﹤0.01% | 3606 |
|
|
2016
Q1 | $610K | Buy |
1,281
+21
| +2% | +$9.45K | ﹤0.01% | 3747 |
|
|
2015
Q4 | $832K | Buy |
1,260
+391
| +45% | +$296K | ﹤0.01% | 3594 |
|
|
2015
Q3 | $682K | Buy |
869
+750
| +630% | +$915K | ﹤0.01% | 3749 |
|
|
2015
Q2 | $157K | Buy |
119
+78
| +190% | +$89.5K | ﹤0.01% | 4748 |
|
|
2015
Q1 | $42K | Buy |
41
+17
| +71% | +$11.2K | ﹤0.01% | 5089 |
|
|
2014
Q4 | $16K | Buy |
+24
| New | +$14.7K | ﹤0.01% | 5446 |
|
Other funds holding ATRA
RG
VCM
EC
